Kuvan Receives Priority Review Status From Health Canada
... form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). ...BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
... form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). ...Kuvan Receives Positive Opinion From CHMP for European Approval
... form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. BioMarin and Merck Serono estimate that Kuvan could be a potential treatment option for approximately 30 percent to 50 percent of the estimated ...New yeast trick for eating favorite food: Details in Nature paper
... the glucose network actively shuts down the galactose network by degrading messenger RNA that would otherwise go on to form the enzymes needed to metabolize galactose. "To find something new in the well-known galactose network after predicting it is extremely exciting," said Matthew Bennett, the first ...European Regulatory Agency Supports OPAXIO(TM) Brand Name for Cell Therapeutics' Lung Cancer Drug
... allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy. Preclinical and clinical studies support that OPAXIO metabolism by lung cancer cells may ...Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
... pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical ...Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
... pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical ...Biochip mimics the body to reveal toxicity of industrial compounds
... by the liver. Because of differences in the type and amount of their drug-metabolizing enzymes, most of which are in the liver, individuals can metabolize a drug or other chemical compound differently. What is harmless to one person may be toxic to another. By arranging the ratio of enzymes on the ...Synvista Therapeutics to be Featured on Wallst.net
... pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical ...Synvista Therapeutics to Present at the BIO InvestorForum 2007
... pharmaceutical markets. The Company's portfolio includes orally bioavailable, organoselenium mimics of glutathione peroxidase. These compounds metabolize lipid peroxides and have the potential to limit myocardial damage subsequent to a myocardial infarction. The Company is developing a clinical ...Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
... form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe. Clinical data suggest that treatment with Kuvan results in significant reductions in blood Phe levels in BH4-responsive patients. It also may ...Marshfield Clinic charges ahead in genetic research
... plan to turn it around in the next year and study it prospectively, where we take the genotypes we have found to be associated with the inability to metabolize coumadin and genotype at the point of diagnosis and prescribe prospectivelythe right drug in the right dose at the right time. Caldwell said ...FDA programs encourage and expedite drug development and approval
... Under the law, this can include a medically plausible subset of persons with a disease that affects a large number of people, such as those who metabolize a type of drug differently than the larger population. Drugs and biologics designated as orphan products are eligible for four major economic ...Milwaukee area biotech ZyStor seeks more funding
... needed to break down glycogen, and at St. Louis University for the treatment of Fabry Disease, which is caused by the lack of the enzyme needed to metabolize lipids. "There's no question that if the animal studies are successful, they will raise the money easily," said Daniel Broderick, managing ...Father of life patents downplays historic role
... you," Chakrabarty said. "I knew nothing about cancer." Patenting life The first life form patent also was a bacterium, one that was able to metabolize hydrocarbons in crude oil, but it didn't happen without a fight. In a case that has parallels to today's debate over embryonic stem cell research, ...ZyStor seeks to raise $15M for clinical trials
... are underway, including a study at St. Louis University for the treatment of Fabry Disease , which is caused by the lack of the enzyme needed to metabolize lipids. Double dipping Daniel Broderick, managing partner at Mason Wells, has said the success of the animal studies are considered critical ...Glossary for The BioPharm Guide to Fermentation and Cell Culture
... that make structures involved in cellular movement. mitochondria Animal-cell organelles that reproduce using their own DNA. They metabolize nutrients to provide the cell with energy and are believed to have once been symbiotic bacteria. Chloroplasts are their plant-cell ...